1. Home
  2. MYGN vs FCBM Comparison

MYGN vs FCBM Comparison

Compare MYGN & FCBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.08

Market Cap

372.1M

Sector

Health Care

ML Signal

HOLD

Logo First Carolina Financial Services Inc.

FCBM

First Carolina Financial Services Inc.

N/A

Current Price

$12.82

Market Cap

393.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
FCBM
Founded
1991
N/A
Country
United States
Employees
2700
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.1M
393.3M
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
MYGN
FCBM
Price
$4.08
$12.82
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.64
N/A
AVG Volume (30 Days)
2.0M
172.1K
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.44
Revenue
$771,400,000.00
N/A
Revenue This Year
$6.86
N/A
Revenue Next Year
$5.45
N/A
P/E Ratio
N/A
$29.34
Revenue Growth
2.33
N/A
52 Week Low
$2.74
$12.17
52 Week High
$8.59
$13.40

Technical Indicators

Market Signals
Indicator
MYGN
FCBM
Relative Strength Index (RSI) 60.67 N/A
Support Level $2.89 N/A
Resistance Level $5.42 N/A
Average True Range (ATR) 0.23 0.00
MACD 0.12 0.00
Stochastic Oscillator 86.49 0.00

Price Performance

Historical Comparison
MYGN
FCBM

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About FCBM First Carolina Financial Services Inc.

First Carolina Financial Services Inc is a bank holding company. The company's activities consist of managing and owning the Bank and its direct and indirect subsidiaries. The Bank provides commercial banking, payment, consumer banking, and wealth management services to small and medium-sized businesses, individuals, professionals, as well as institutions of higher education. It has four primary lines of business: Commercial Banking, Payments, Consumer Banking and Wealth Management. The reportable segments are Community Banking and BM Tech. The majority of revenue is derived from the Community Banking segment, which comprises activities of a traditional banking institution, gathering deposits and originating loans for portfolio in its respective primary market areas.

Share on Social Networks: